EBITDA margin společnosti Theratechnologies
Jaká je hodnota metriky EBITDA margin společnosti Theratechnologies?
Hodnota metriky EBITDA margin společnosti Theratechnologies, Inc. je -27.40%
Jaká je definice metriky EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin společností v sektoru Health Care sektor na TSX ve srovnání se společností Theratechnologies
Čemu se věnuje společnost Theratechnologies?
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.
Firmy s metrikou ebitda margin podobnou společnosti Theratechnologies
- Hodnota metriky EBITDA margin společnosti QYOU Media je -27.60%
- Hodnota metriky EBITDA margin společnosti Appian je -27.58%
- Hodnota metriky EBITDA margin společnosti FLYHT Aerospace Solutions je -27.53%
- Hodnota metriky EBITDA margin společnosti Axion Ventures je -27.49%
- Hodnota metriky EBITDA margin společnosti Tejas Networks je -27.41%
- Hodnota metriky EBITDA margin společnosti SiTime Corp je -27.41%
- Hodnota metriky EBITDA margin společnosti Theratechnologies je -27.40%
- Hodnota metriky EBITDA margin společnosti China Shenghai Food je -27.31%
- Hodnota metriky EBITDA margin společnosti Immunogen je -27.28%
- Hodnota metriky EBITDA margin společnosti ARSS Infrastructure Projects je -27.27%
- Hodnota metriky EBITDA margin společnosti QuickLogic je -27.23%
- Hodnota metriky EBITDA margin společnosti Accel Transmatic je -27.21%
- Hodnota metriky EBITDA margin společnosti Sanara MedTech je -27.20%